- About ACRO
- ACRO Updates
- Policy Views
- Meetings + Events
- Media Center
- Contact Us
The Communications Committee is comprised of member company executives from the areas of global communications, corporate marketing and strategy. Members help to shape ACRO's strategic messaging and public statements, highlighting the CRO industry’s expertise in all aspects of clinical research. The committee directs efforts aimed at strengthening the public’s understanding about clinical research and providing outreach to key stakeholders and the media and overseeing educational events. The 2013 Committee Chair is Chris Tama of PAREXEL.
Ethics and Regulatory Compliance Committee
The Ethics and Regulatory Compliance Committee is made up of member company representatives with expertise in areas such as regulatory affairs, medical affairs, quality assurance and clinical operations. Members lead the Association’s regulatory efforts, especially regarding the FDA. The Committee has worked on initiatives such as the development of ACRO's Code of Ethics and position papers. This group considers the development of industry standards and best practices, directs collaborative initiatives with public-private consortiums and other organizations, and meets regularly with biopharmaceutical leaders, regulators and health officials, peer associations, academic groups and others.
Legal and Government Affairs Committee
The Legal and Government Affairs Committee is chaired by the ACRO Secretary and made up of General Counsels of all Regular Member companies, the ACRO Executive Director and others designees. The committee advises the Association in regard to public policy, legislation and regulation, and directs the advocacy activities of Association staff. The 2013 Committee Chair is Douglas Batt of PAREXEL.
EU Scientific and Regulatory Committee
The EU Scientific and Regulatory Committee is comprised of representatives from fields including global regulatory affairs, clinical operations and medical affairs. The committee advises the Association on policy and regulation impacting clinical research throughout Europe. ACRO has regular interaction with officials at the European Medicines Agency (EMA), European Commission and other EU regulatory authorities, and helps directs related activities on issues such as the continued implementation of the Clinical Trials Directive. The committee also engages in specific country regulatory issues throughout Europe.
Global Data Protection and Privacy Committee
The Global Data Protection and Privacy Committee is comprised of member company data protection and privacy professionals and leads the Association’s data protection and privacy efforts. This Committee engages in collaborative initiatives with public-private consortiums and other organizations, and meets regularly with biopharmaceutical leaders, regulators and data protection authorities, peer associations, academic groups and other stakeholders. The Committee also monitors and responds to country-specific data protection and privacy regulatory issues. The 2013 Committee Chair is Uwe W Fiedler of PAREXEL.